These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 17538953)

  • 1. Possible cross-regulation of the E prostanoid receptors.
    Tober KL; Thomas-Ahner JM; Maruyama T; Oberyszyn TM
    Mol Carcinog; 2007 Aug; 46(8):711-5. PubMed ID: 17538953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice.
    Minami T; Nakano H; Kobayashi T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Ito S
    Br J Pharmacol; 2001 Jun; 133(3):438-44. PubMed ID: 11375261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of UVB on E prostanoid receptor expression in murine skin.
    Tober KL; Thomas-Ahner JM; Kusewitt DF; Oberyszyn TM
    J Invest Dermatol; 2007 Jan; 127(1):214-21. PubMed ID: 16917495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the EP1 receptor for prostaglandin E2 promotes skin tumor progression.
    Surh I; Rundhaug J; Pavone A; Mikulec C; Abel E; Fischer SM
    Mol Carcinog; 2011 Jun; 50(6):458-68. PubMed ID: 21268127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development.
    Tober KL; Wilgus TA; Kusewitt DF; Thomas-Ahner JM; Maruyama T; Oberyszyn TM
    J Invest Dermatol; 2006 Jan; 126(1):205-11. PubMed ID: 16417238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anorexia and cachexia in prostaglandin EP1 and EP3 subtype receptor knockout mice bearing a tumor with high intrinsic PGE2 production and prostaglandin related cachexia.
    Wang W; Andersson M; Lönnroth C; Svanberg E; Lundholm K
    J Exp Clin Cancer Res; 2005 Mar; 24(1):99-107. PubMed ID: 15943039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGE(2) receptor EP1 renders dopaminergic neurons selectively vulnerable to low-level oxidative stress and direct PGE(2) neurotoxicity.
    Carrasco E; Casper D; Werner P
    J Neurosci Res; 2007 Nov; 85(14):3109-17. PubMed ID: 17868147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of E prostanoid receptors in murine and human non-melanoma skin cancer.
    Lee JL; Kim A; Kopelovich L; Bickers DR; Athar M
    J Invest Dermatol; 2005 Oct; 125(4):818-25. PubMed ID: 16185283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho-kinase mediates spinal nitric oxide formation by prostaglandin E2 via EP3 subtype.
    Matsumura S; Abe T; Mabuchi T; Katano T; Takagi K; Okuda-Ashitaka E; Tatsumi S; Nakai Y; Hidaka H; Suzuki M; Sasaki Y; Minami T; Ito S
    Biochem Biophys Res Commun; 2005 Dec; 338(1):550-7. PubMed ID: 16188227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the prostaglandin E2/E-prostanoid 2 receptor signaling pathway in abscess formation in rat zymosan-induced pleurisy.
    Inada T; Arai K; Kawamura M; Hatanaka K; Sato Y; Noshiro M; Harada Y
    J Pharmacol Exp Ther; 2009 Dec; 331(3):860-70. PubMed ID: 19726696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of cyclooxygenase-2 and EP3 prostaglandin receptor in acute herpetic but not postherpetic pain in mice.
    Takasaki I; Nojima H; Shiraki K; Sugimoto Y; Ichikawa A; Ushikubi F; Narumiya S; Kuraishi Y
    Neuropharmacology; 2005 Sep; 49(3):283-92. PubMed ID: 15925391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E(2)-EP(3) signaling suppresses skin inflammation in murine contact hypersensitivity.
    Honda T; Matsuoka T; Ueta M; Kabashima K; Miyachi Y; Narumiya S
    J Allergy Clin Immunol; 2009 Oct; 124(4):809-18.e2. PubMed ID: 19541354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of prostanoid EP agonists on mouse intraocular pressure.
    Saeki T; Ota T; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2201-8. PubMed ID: 19117925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cyclooxygenase-1, prostaglandin E2 and EP1 receptors in acid-induced HCO3- secretion in stomach.
    Takeuchi K; Aihara E; Sasaki Y; Nomura Y; Ise F
    J Physiol Pharmacol; 2006 Dec; 57(4):661-76. PubMed ID: 17229989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E potentiates the immunologically stimulated histamine release from human peripheral blood-derived mast cells through EP1/EP3 receptors.
    Wang XS; Lau HY
    Allergy; 2006 Apr; 61(4):503-6. PubMed ID: 16512814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression pattern of prostaglandin E synthase and EP receptor isoforms in normal mouse skin and preinvasive skin neoplasms.
    Neumann M; Dülsner E; Fürstenberger G; Müller-Decker K
    Exp Dermatol; 2007 May; 16(5):445-53. PubMed ID: 17437488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A proposed COX-2 and PGE(2) receptor interaction in UV-exposed mouse skin.
    Chun KS; Langenbach R
    Mol Carcinog; 2007 Aug; 46(8):699-704. PubMed ID: 17570497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins enhance epidermal growth factor-induced DNA synthesis in hepatocytes by stimulation of E prostanoid 3 and F prostanoid receptors.
    Meisdalen K; Dajani OF; Christoffersen T; Sandnes D
    J Pharmacol Exp Ther; 2007 Sep; 322(3):1044-50. PubMed ID: 17567965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PGE(2) induces COX-2 expression in podocytes via the EP(4) receptor through a PKA-independent mechanism.
    Faour WH; Gomi K; Kennedy CR
    Cell Signal; 2008 Nov; 20(11):2156-64. PubMed ID: 18762248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.